Namhoon Cho

General Partner and CEO

14 past transactions

Soomvi

Venture Round in 2024
Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving system services. It develops advanced drones that are engineered to enhance safety and performance through the integration of sophisticated technology. These drones feature a sensor-isolated and vibration-resistant structural design, enabling reliable operation in demanding environments. They are equipped with capabilities for real-time synchronization and communication of flight information, along with a backup control system for added safety. Soomvi's innovations aim to meet the needs of various industrial applications, enhancing operational efficiency while ensuring security.

Kookmin Bio

Series B in 2024
Kookmin Bio is a biotechnology company specializing in the development of bio-food and pharmaceutical materials. It focuses on creating microbiome-regulating products and new drugs for preventive medicines, with a core competency in strain development and fermentation production technology.

searchM

Venture Round in 2024
searchM is a digital marketing and advertising company.

Daton

Seed Round in 2024
Daton is an IoT solution provider specializing in artificial intelligence and IoT solutions. The company offers products like Tech-See, an AI-driven video monitoring system, and Xpotti, an intelligent security solution for schools and public areas. Daton focuses on enhancing safety and efficiency across various sectors through advanced AI technologies.

Ingenium Therapeutics

Series A in 2023
Ingenium Therapeutics is a company focused on the commercialization of natural killer (NK) cell-based immunotherapy for cancer treatment. By leveraging solid foundational research, Ingenium Therapeutics aims to develop innovative treatments targeting intractable leukemia and other cancers. The company specializes in utilizing NK cells, which are vital components of the human immune system, to create effective immuno-anticancer therapies. Through its commitment to advancing cancer care, Ingenium Therapeutics seeks to provide patients with new therapeutic options that enhance the immune response against tumors.

MitoImmune Therapeutics

Venture Round in 2023
MitoImmune Therapeutics is a biotechnology company focused on drug research and development aimed at treating mitochondrial dysfunction and various cellular disorders. The company specializes in creating therapies for diseases related to mitochondrial dysfunction, including necrotic and inflammatory conditions. By developing targeted treatments, MitoImmune Therapeutics aims to enhance the quality of life for patients suffering from these complex health issues.

Creamo

Venture Round in 2023
Creamo develops block-based games and physical coding kits featuring interactive smart blocks for children. Its offerings enable kids to use IoT technology during play with real objects, fostering learning and development by providing an educational environment where they can think and create.

Ingenium Therapeutics

Seed Round in 2022
Ingenium Therapeutics is a company focused on the commercialization of natural killer (NK) cell-based immunotherapy for cancer treatment. By leveraging solid foundational research, Ingenium Therapeutics aims to develop innovative treatments targeting intractable leukemia and other cancers. The company specializes in utilizing NK cells, which are vital components of the human immune system, to create effective immuno-anticancer therapies. Through its commitment to advancing cancer care, Ingenium Therapeutics seeks to provide patients with new therapeutic options that enhance the immune response against tumors.

Yellowknife

Seed Round in 2021
Yellowknife is a company focused on enhancing vehicle experiences through a custom digital cluster sharing and usage platform. It aims to provide tailored travel experiences for a range of future transportation methods. The company develops a mobility display that allows users to interact with their vehicles through a customizable screen interface. This interface can take the form of a cover skin, complementing the existing liquid-crystal display digital instrument panel provided by vehicle manufacturers. By offering personalized display options, Yellowknife caters to the specific needs and preferences of users, fostering a more engaging and adaptable driving experience.

Endorobotics

Series A in 2021
Endorobotics manufactures endoscopic robotic medical equipment. Its key product attaches robotic arms to flexible endoscopes, enabling precise tissue dissection, suturing, and lesion removal within the gastrointestinal tract. This facilitates minimally invasive surgeries, reducing recovery time, avoiding external scarring, and improving patient outcomes in digestive disease treatment.

Nemesis

Seed Round in 2021
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and wireless communication, which provide compact, low-power, and accurate semiconductor solutions that anyone can use. Nemesis semiconductor-based intelligent bio signal processing solution can be expanded to diagnose biomarkers in areas such as heart rate, electrocardiogram, blood pressure, and virus detection. Nemesis will do everything possible to improve the quality of our partners' products and services as a result of this.

YPER

Series A in 2020
YPER is a vehicle management and car wash app.

Solomonster

Seed Round in 2020
Advertising agency, digital content development, supply, pop culture art planning/e-commerce

CatackH

Venture Round in 2020
The world's first CFRP recycling company by chemical decomposition technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.